Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody–positive individuals

The 1982 revised criteria for the classification of systemic lupus erythematosus

1982 • 14,553 citations

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

2006 • 6,655 citations

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop

1999 • 2,708 citations

A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

2005 • 1,949 citations

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update

2002 • 1,909 citations

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

1995 • 1,467 citations

Primary Prevention of Ischemic Stroke

2006 • 1,367 citations

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

1995 • 1,179 citations

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

2000 • 1,046 citations

Criteria for the Diagnosis of Lupus Anticoagulants: An Update

1995 • 954 citations

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

2003 • 952 citations

Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men

2006 • 785 citations

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1992 • 702 citations

Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

1994 • 570 citations

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

1992 • 528 citations

Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients

1994 • 507 citations

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry

1996 • 439 citations

Thrombosis in the Young: Epidemiology and Risk Factors. A Focus on Venous Thrombosis

1997 • 332 citations

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

2002 • 327 citations

An Update on Aspirin in the Primary Prevention of Cardiovascular Disease

2003 • 265 citations

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

1993 • 241 citations

Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

2004 • 212 citations

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

1998 • 208 citations

High thrombosis rate after fetal loss in antiphospholipid syndrome: Effective prophylaxis with aspirin

2001 • 191 citations

Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.

2002 • 188 citations

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

2005 • 172 citations

Prophylactic Antithrombotic Therapy for Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies

2000 • 154 citations

Cardiac Remodeling: Mechanism and Treatment

2006 • 130 citations

Prophylaxis of the antiphospholipid syndrome: a consensus report

2003 • 99 citations

Aspirin in the prevention and treatment of venous thromboembolism

2006 • 85 citations

A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)

2005 • 75 citations

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials

1994 • 72 citations

Multiple human endogenous retrovirus (HERV-K) loci with <i>gag</i> open reading frames in the human genome

1997 • 65 citations

Genome-Wide Scan for Pulse Pressure in the National Heart, Lung and Blood Institute’s Framingham Heart Study

2004 • 65 citations

Therapy Insight: systemic lupus erythematosus as a risk factor for cardiovascular disease

2005 • 61 citations

Antiphospholipid antibodies and thrombosis: strength of association

2003 • 59 citations

Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus

2006 • 48 citations

Antiphospholipid Syndrome in Systemic Lupus Erythematosus: Is the Whole Greater Than the Sum of Its Parts?

2005 • 42 citations

Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.

1999 • 31 citations

Antiphospholipid antibodies: update on detection, pathophysiology, and treatment

2004 • 29 citations

Aspirin overprescription in primary cardiovascular prevention

2005 • 21 citations

Molecular Mechanisms of Disseminated Intravascular Coagulation

2003 • 14 citations

The lady aspirin for cardiovascular disease

2005 • 12 citations